Skip to main content

Drug-Induced Alopecia

  • Chapter
Book cover Cutaneous Drug Eruptions

Abstract

Hair loss is a common complaint, and an understanding of the hair cycle is vital in order to interpret whether hair loss is secondary to medication use, as the use of prescription medications is widespread. When there is a temporal association between the onset of hair loss and the commencement of a medication, the medication is commonly presumed to have caused the hair loss. Drug-induced alopecia is a result of either rapid termination of the normal growth phase (anagen effluvium) or a premature conversion of actively growing hairs into the dormant, resting phase (telogen effluvium). Hair loss, in particular telogen effluvium, may, however, occur in response to a number of triggers including fever, hemorrhage, severe illness, and stress. Because hair loss is often delayed and because diffuse alopecia often begins sub-clinically, it may be challenging to determine the primary of alopecia. As a rule of thumb, adverse drug reactions are reversible provided the causative drug is avoided; however, identifying the culprit medication can be difficult. This chapter will review the normal hair cycle and discuss the major drugs that have been associated with alopecia, along with their mechanism (s) of action.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • Abbasi NR, Orlow SJ. Lichen planopilaris noted during etanercept therapy in a child with severe psoriasis. Pediatr Dermatol. 2009;26(1):118.

    Article  PubMed  Google Scholar 

  • Apsner R, Horl WH, Sunder-Plassmann G. Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation. Blood. 2001;97(9):2914–5.

    Article  CAS  PubMed  Google Scholar 

  • Balter S, Hopewell JW, Miller DL, Wagner LK, Zelefsky MJ. Fluoroscopically guided interventional procedures: a review of radiation effects on patients’ skin and hair. Radiology. 2010;254(2):326–41.

    Article  PubMed  Google Scholar 

  • Bergfeld WF. Retinoids and hair growth. J Am Acad Dermatol. 1998;39(2):S86–9.

    Article  CAS  PubMed  Google Scholar 

  • Chon SY, Champion RW, Geddes ER, Rashid RM. Chemotherapy-induced alopecia. J Am Acad Dermatol. 2012;67(1):37–47.

    Article  Google Scholar 

  • Clarke JT, Price H, Clarke S, George R, Miller JJ. Acquired kinking of the hair caused by acitretin. J Drugs Dermatol. 2007;6(9):937–8.

    PubMed  Google Scholar 

  • Cöster C, Tyrenius A. Reversible hair loss with nitrofurantoin treatment. Läkartidningen. 1971;68(30):3366 (Swedish).

    PubMed  Google Scholar 

  • Duvic M, Lemak NA, Valero V, Hymes SR, Farmer KL, Hortobagyi GN, et al. A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol. 1996;35(1):74–8.

    Article  CAS  PubMed  Google Scholar 

  • Eker HE, Cok OY, Aribogan A. Alopecia associated with gabapentin in the treatment of neuropathic pain. J Pain Symptom Manage. 2009;37(3):e5–6.

    Article  PubMed  Google Scholar 

  • Flesch P. Inhibition of keratinizing structures by systemic drugs. Pharmacol Rev. 1963;58:653.

    Google Scholar 

  • Garcovich S, Manco S, Zampetti A, et al. Onset of lichen planopilaris during treatment with etanercept. Br J Dermatol. 2008;158:1161–3.

    Article  CAS  PubMed  Google Scholar 

  • Goh C. Hepatitis C treatment and alopecia totalis. J Investig Dermatol Symp Proc. 2013;16:S59–60.

    Article  CAS  PubMed  Google Scholar 

  • Graeber CW, Lapkin RA. Metoprolol and alopecia. Cutis. 1981;28(6):633–4.

    CAS  PubMed  Google Scholar 

  • Grevelman EG, Breed WPM. Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol. 2005;16(3):352–8.

    Article  CAS  PubMed  Google Scholar 

  • Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol. 2002;27:389–95.

    Article  CAS  PubMed  Google Scholar 

  • Hedenmalm K, Sundström A, Spigset O. Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs). Pharmacoepidemiol Drug Saf. 2006;15(10):719–25.

    Article  CAS  PubMed  Google Scholar 

  • Hilder RJ. Propranolol and alopecia. Cutis. 1979;24(1):63–4.

    CAS  PubMed  Google Scholar 

  • Holler PD, Cotsarelis G. Retinoids putting the “a” in alopecia. J Invest Dermatol. 2013;133:285–6.

    Article  CAS  PubMed  Google Scholar 

  • Kartal ED, Alpat SN, Ozgunes I, Usluer G. Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Eur J Gastroenterol Hepatol. 2007;19(9):817–20.

    Article  PubMed  Google Scholar 

  • Leaker B, Whitworth JA. Alopecia associated with captopril treatment. Aust N Z J Med. 1984;14(6):866.

    Article  CAS  PubMed  Google Scholar 

  • Martin CM, Southwick EG, Maibach HI. Propranolol induced alopecia. Am Heart J. 1973;86(2):236–7.

    Article  CAS  PubMed  Google Scholar 

  • Mcgovern B, Garan H, Kelly E, Ruskin JN. Adverse reactions during treatment with amiodarone hydrochloride. Br Med J. 1983;287(6386):175–80.

    Article  CAS  Google Scholar 

  • McKinney PA, Finkenbine RD, DeVane CL. Alopecia and mood stabilizer therapy. Ann Clin Psychiatry. 1996;8(3):183–5.

    Article  CAS  PubMed  Google Scholar 

  • Mercke Y, Sheng H, Khan T, Lippmann S. Hair loss in psychopharmacology. Ann Clin Psychiatry. 2000;12(1):35–42.

    Article  CAS  PubMed  Google Scholar 

  • Miwa H, Kondo T. Hair loss induced by dopamine agonist: case report and review of the literature. Parkinsonism Relat Disord. 2003;10(1):51–2.

    Article  PubMed  Google Scholar 

  • Mortimer PS, Dawber RPR. Hair loss and lithium. Int J Dermatol. 1984;23(9):603–4.

    Article  CAS  PubMed  Google Scholar 

  • Motel PJ. Captopril and alopecia: a case report and review of known cutaneous reactions in captopril use. J Am Acad Dermatol. 1990;23(1):124–5.

    Article  CAS  PubMed  Google Scholar 

  • Munstedt K, Manthey N, Sachsse S, Vahrson H. Changes in self-concept and body image during alopecia induced cancer chemotherapy. Support Care Cancer. 1997;5:139–43.

    Article  CAS  PubMed  Google Scholar 

  • Nagao T, Ibayashi S, Fujii K, Sugimori H, Sadoshima S, Fujishima M. Treatment of warfarin-induced hair loss with ubidecarenone. Lancet. 1995;346(8982):1104–5.

    Article  CAS  PubMed  Google Scholar 

  • Omazzi B, Prada A, Borroni G, Sacrini F. Irreversible slopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: case report and published work review. Hepatol Res. 2012;42:1248–51.

    Article  PubMed  Google Scholar 

  • Orfanos C, Happle R. Hair and hair diseases. Berlin: Springer; 1990.

    Book  Google Scholar 

  • Patel M, Harrison S, Sinclair R. Drugs and hair loss. Dermatol Clin. 2013;31:67–73.

    Article  CAS  PubMed  Google Scholar 

  • Pearce DJ, Klinger S, Ziel KK, Murad EJ, Rowell R, Feldman SR. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis. Arch Dermatol. 2006;142:1000–4.

    Article  CAS  PubMed  Google Scholar 

  • Pettignano R, Heard ML, Labuz MD, Wagoner SF, Fortenberry J. Hair loss after extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2003;4(3):363–6.

    Article  PubMed  Google Scholar 

  • Piraccini BM, Iorizzo M, Rech G, Tosti A. Drug-induced hair disorders. Curr Drug Saf. 2006;1:301–5.

    Article  CAS  PubMed  Google Scholar 

  • Podlipnik S, Giavedoni P, San-Román L, Ferrando J. Square alopecia: a new type of transient alopecia of the scalp following fluoroscopically endovascular embolization. Int J Trichology. 2013;5(4):201–3.

    Article  PubMed Central  PubMed  Google Scholar 

  • Rosman IS, Anadkat MJ. Tufted hair folliculitis in a woman treated with trastuzumab. Target Oncol. 2010;5:295–6.

    Article  PubMed  Google Scholar 

  • Ruiz-Ramos J, Salavert-Lleti M, Monte-Boquet E, Lorente-Fernández L, Gil-Gómez I, Poveda-Andrés JL. Anidulafungin-induced alopecia. Ann Pharmacother. 2014;48(5):660–2.

    Article  CAS  PubMed  Google Scholar 

  • Samuel LM, Davie M, Starkey IR. Amiodarone and hair loss. Postgrad Med J. 1992;68(803):771.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sarris E, Tsele E, Bagiatoudi G, Salpigidis K, Stavrianaki D, Kaklamanis L, et al. Diffuse alopecia in a hemodialysis patient caused by a low-molecular-weight heparin, tinzaparin. Am J Kidney Dis. 2003;41(5):15.

    Article  Google Scholar 

  • Shapiro J, Wiseman M, Lui H. Practical management of hair loss. Can Fam Physician. 2000;46:1469–77.

    PubMed Central  CAS  PubMed  Google Scholar 

  • Shelley ED, Shelley WB. Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol. Cutis. 1985;35(2):148–9.

    CAS  PubMed  Google Scholar 

  • Signore RJ, von Weiss J. Alopecia of myxedema: clinical response to levothyroxine sodium. J Am Acad Dermatol. 1991;25(5):902–4.

    Article  CAS  PubMed  Google Scholar 

  • Tosti A, Pazzaglia M. Drug reactions affecting hair: diagnosis. Dermatol Clin. 2007;25(2):223–31.

    Article  CAS  PubMed  Google Scholar 

  • Tosti A, Misciali C, Bardazzi F, Fanti PA, Varotti C. Telogen Effluvium due to recombinant interferon alpha-2b. Dermatology. 1992;184(2):124–5.

    Article  CAS  PubMed  Google Scholar 

  • Tosti A, Piraccini BM, Vincenzi C, Misciali C. Permanent alopecia after busulfan chemotherapy. Br J Dermatol. 2005;152:1056–8.

    Article  CAS  PubMed  Google Scholar 

  • Tricot L, Lebbé C, Pillebout E, Martinez F, Legendre C, Thervet E. Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. Transplantation. 2005;80(11):1546–9.

    Article  CAS  PubMed  Google Scholar 

  • Umlas J, Harken DE. Warfarin-induced alopecia. Cutis. 1988;42(1):63–4.

    CAS  PubMed  Google Scholar 

  • Wang YY, Po HL. Enoxaparin-induced alopecia in patients with cerebral venous thrombosis. J Clin Pharm Ther. 2006;31(5):513–7.

    Article  PubMed  Google Scholar 

  • Warnock JK, Sieg K, Willsie D, Stevenson EK, Kestenbaum T. Drug-related alopecia in patients treated with tricyclic antidepressants. J Nerv Ment Dis. 1991;179(7):441–2.

    Article  CAS  PubMed  Google Scholar 

  • Yoshioka H, Matsuda I. Loss of hair related to gentamicin treatment. JAMA. 1970;211(1):123.

    Article  CAS  PubMed  Google Scholar 

  • Yun SJ, Kim SJ. Hair loss pattern due to chemotherapy-induced anagen effluvium: a cross-sectional observation. Dermatology. 2007;215:36–40.

    Article  CAS  PubMed  Google Scholar 

  • Zuk DM, Koh A, Imes S, Shapiro AM, Senior PA. Three cases of alopecia following clinical islet transplantation. Am J Transplant. 2011;11:163–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gretchen W. Frieling MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Lesiak, K., Bartlett, J.R., Frieling, G.W. (2015). Drug-Induced Alopecia. In: Hall, J., Hall, B. (eds) Cutaneous Drug Eruptions. Springer, London. https://doi.org/10.1007/978-1-4471-6729-7_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6729-7_20

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6728-0

  • Online ISBN: 978-1-4471-6729-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics